The Conversation (0)
BioCorRx announced the completion and beta launch of its proprietary mobile application for use by licensed behavioral specialists and individuals in treatment for opioid and alcohol use disorders.
BioCorRx (OTCQB:BICX) announced the completion and beta launch of its proprietary mobile application for use by licensed behavioral specialists and individuals in treatment for opioid and alcohol use disorders.
As quoted in the press release:
The application is scheduled to be made available in the Apple App Store and Google Play September 21, 2017.
In April, the Company entered into an agreement with DynamiCare Health™, Inc. to develop a co-branded mobile application to support patients participating in medication-assisted treatment (MAT) programs for the treatment of alcohol or opioid use disorder and specifically receiving long-term naltrexone treatment.
The mobile application, DynamiCare Rewards™ with BioCorRx CBT, is designed to offer patients a self-guided (yet supervised by licensed professionals), interactive version of BioCorRx’s proprietary, naltrexone specific, Cognitive Behavioral Therapy (CBT) program.
Click here to read the full press release.
Source: www.marketwired.com